{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28215136",
  "DateCompleted": {
    "Year": "2017",
    "Month": "08",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2017",
    "Month": "08",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1441-2772",
      "JournalIssue": {
        "Volume": "19",
        "Issue": "1",
        "PubDate": {
          "Year": "2017",
          "Month": "Mar"
        }
      },
      "Title": "Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine",
      "ISOAbbreviation": "Crit Care Resusc"
    },
    "ArticleTitle": "Protocol and statistical analysis plan for the Randomised Evaluation of Active Control of Temperature versus Ordinary Temperature Management (REACTOR) trial.",
    "Pagination": {
      "StartPage": "81",
      "EndPage": "87",
      "MedlinePgn": "81-87"
    },
    "Abstract": {
      "AbstractText": [
        "Body temperature can be reduced in febrile patients in the intensive care unit using medicines and physical cooling devices, but it is not known whether systematically preventing and treating fever reduces body temperature compared with standard care.",
        "To describe the study protocol and statistical analysis plan for the Randomised Evaluation of Active Control of Temperature versus Ordinary Temperature Management (REACTOR) trial.",
        "Protocol for a phase II, multicentre trial to be conducted in Australian and New Zealand ICUs admitting adult patients. We will recruit 184 adults without acute brain injury who are expected to be ventilated in the ICU beyond the day after randomisation. We will use open, random, parallel assignment to systematic prevention and treatment of fever, or to standard temperature management.",
        "The primary end point will be mean body temperature, calculated from body temperatures measured 6-hourly for 7 days (168 hours) or until ICU discharge, whichever is sooner. Secondary end points are ICU-free days, in-hospital and cause-specific mortality (censored at Day 90) and survival time to Day 90 (censored at hospital discharge).",
        "The trial will determine whether active temperature control reduces body temperature compared with standard care. It is primarily being conducted to establish whether a phase III trial with a patient-centred end point of Day 90 mortality is justified and feasible."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Intensive Care Unit, Wellington Regional Hospital, Wellington, New Zealand. paul.young@ccdhb.org.nz."
          }
        ],
        "LastName": "Young",
        "ForeName": "Paul J",
        "Initials": "PJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia."
          }
        ],
        "LastName": "Bailey",
        "ForeName": "Michael J",
        "Initials": "MJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Research Institute of New Zealand, Wellington, New Zealand."
          }
        ],
        "LastName": "Beasley",
        "ForeName": "Richard W",
        "Initials": "RW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Research Institute of New Zealand, Wellington, New Zealand."
          }
        ],
        "LastName": "Freebairn",
        "ForeName": "Ross C",
        "Initials": "RC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Critical Care Division, The George Institute for Global Health, Sydney, NSW, Australia."
          }
        ],
        "LastName": "Hammond",
        "ForeName": "Naomi E",
        "Initials": "NE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Intensive Care Unit, The Canberra Hospital, Canberra, ACT, Australia."
          }
        ],
        "LastName": "Haren",
        "ForeName": "Frank M P van",
        "Initials": "FM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Critical Care Division, The George Institute for Global Health, Sydney, NSW, Australia."
          }
        ],
        "LastName": "Harward",
        "ForeName": "Meg L",
        "Initials": "ML"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Intensive Care Unit, Christchurch Hospital, Christchurch, New Zealand."
          }
        ],
        "LastName": "Henderson",
        "ForeName": "Seton J",
        "Initials": "SJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Research Institute of New Zealand, Wellington, New Zealand."
          }
        ],
        "LastName": "Mackle",
        "ForeName": "Diane M",
        "Initials": "DM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Research Institute of New Zealand, Wellington, New Zealand."
          }
        ],
        "LastName": "McArthur",
        "ForeName": "Colin J",
        "Initials": "CJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Research Institute of New Zealand, Wellington, New Zealand."
          }
        ],
        "LastName": "McGuinness",
        "ForeName": "Shay P",
        "Initials": "SP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Critical Care Division, The George Institute for Global Health, Sydney, NSW, Australia."
          }
        ],
        "LastName": "Myburgh",
        "ForeName": "John A",
        "Initials": "JA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Critical Care Division, The George Institute for Global Health, Sydney, NSW, Australia."
          }
        ],
        "LastName": "Saxena",
        "ForeName": "Manoj K",
        "Initials": "MK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Research Institute of New Zealand, Wellington, New Zealand."
          }
        ],
        "LastName": "Turner",
        "ForeName": "Anne",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia."
          }
        ],
        "LastName": "Webb",
        "ForeName": "Steve A R",
        "Initials": "SA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia."
          }
        ],
        "LastName": "Bellomo",
        "ForeName": "Rinaldo",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "CollectiveName": "\nThe ANZICS Clinical Trials Group\n\t\t\t\t"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial, Phase II",
      "Comparative Study",
      "Journal Article",
      "Multicenter Study",
      "Randomized Controlled Trial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Crit Care Resusc",
    "NlmUniqueID": "100888170",
    "ISSNLinking": "1441-2772"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Protocols"
    },
    {
      "QualifierName": [
        "prevention & control",
        "therapy"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Intensive Care Units"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Research Design"
    }
  ]
}